Signals such as pneumonia and asthenia showed borderline significance after correction (both p_FDR≈0.0508).
← all excerpts
Safety recommendations for ALK tyrosine kinase inhibitors in non-small cell lung cancer: evidence from FAERS and CVARDD real-world databases.
1
—
—